Monitoring of residual heparinisation after cardiac surgery with thromboelastography (TEG) and postoperative bloodloss

Monitoring of residual heparinisation after cardiac surgery with thromboelastography (TEG) and postoperative bloodloss - RESTANT study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON43335

Enrollment

Registered

2016-11-10

Start date

2017-05-15

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

residual blood anticoagulation residual heparinisation

Interventions

Cardio-pulmonary bypass

Heparine

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: >18 years mentally competent elective CABG and (multiple) heart valve surgery or multiple heart valve surgery alone signed informed consent

Exclusion criteria

Exclusion criteria: congenital or acquired coagulation disorder cardiac re-operation within 1 year pregnancy INR > 1.8

Design outcomes

Primary

Measure	Time frame
Primary goal of this reasearch is to determine to which extent residual heparinisation is correlated with post-operative blood loss after elective cardiac surgery.	—

Secondary

Measure	Time frame
Secondary outcome of this reasearch is to determine to which extent TEG and ACT can predict post-operative blood loss and to which extent residual heparinisation is associated with thrombocyte dysfunction.	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)